Plain English Summary Background and study aims Overweight and obesity are considered major health problems that contribute to a reduction in quality of life and increase mortality death risk. Both conditions have a high prevalence across the world reaching epidemic numbers. Weight loss supplements are becoming popular as a weight to lose fat. Garcinia cambogia GC is a fruit that has an ingredient that might incresae weight loss. Glucomannan GNN is an ingredient derived from a plant that is also marketed for weight loss.
The aim of this study is to evaluate the effects of the administration of Garcinia cambogia GC and Glucomannan GNN on long-term weight loss in people with overweight or obesity.
Who can participate? Adults aged 18 and older who have a BMI over What does the study involve? Participants have a balanced diet Mediterranean diet , regular meals and intake of plenty of water. Standardised extracts of Garciania cambogia Participants are treated with GC mg , twice a day, half an hour before lunch and dinner and GNN mg , twice a day, half an hour before lunch and dinner for six months.
Participants are assessed for their weight and fat percentage. What are the possible benefits and risks of participating? Participants may benefit in improvements in their condition. There are no direct risks with participating.
Where is the study run from? Scientifics Aesthetics Clinics of the body Spain When is the study starting and how long is it expected to run for? June to October Who is funding the study?
